120 related articles for article (PubMed ID: 29795752)
1. Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2).
Pei Z; Mendonca R; Gazzard L; Pastor R; Goon L; Gustafson A; VanderPorten E; Hatzivassiliou G; Dement K; Cass R; Yuen PW; Zhang Y; Wu G; Lin X; Liu Y; Sellers BD
ACS Med Chem Lett; 2018 May; 9(5):417-421. PubMed ID: 29795752
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
Sari S; Tomek P; Leung E; Reynisson J
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2.
Tijono SM; Palmer BD; Tomek P; Flanagan JU; Henare K; Gamage S; Braun L; Ching LM
Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145311
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of L- and D-5-[
Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J
Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073
[TBL] [Abstract][Full Text] [Related]
5. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
[TBL] [Abstract][Full Text] [Related]
6. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
7. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
8. Development of a mass spectrometry-based tryptophan 2, 3-dioxygenase assay using liver cytosol from multiple species.
Wang J; Takahashi RH; DeMent K; Gustafson A; Kenny JR; Wong SG; Yan Z
Anal Biochem; 2018 Sep; 556():85-90. PubMed ID: 29959909
[TBL] [Abstract][Full Text] [Related]
9. Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice.
Zhang R; Wang Y; Liu D; Luo Q; Du P; Zhang H; Wu W
Front Pharmacol; 2022; 13():870848. PubMed ID: 35571116
[TBL] [Abstract][Full Text] [Related]
10. Current state on tryptophan 2,3-dioxygenase inhibitors: a patent review.
Kozlova A; Frédérick R
Expert Opin Ther Pat; 2019 Jan; 29(1):11-23. PubMed ID: 30526149
[TBL] [Abstract][Full Text] [Related]
11. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
[TBL] [Abstract][Full Text] [Related]
12. TDO2 and tryptophan metabolites promote kynurenine/AhR signals to facilitate glioma progression and immunosuppression.
Zhong C; Peng L; Tao B; Yin S; Lyu L; Ding H; Yang X; Peng T; He H; Zhou P
Am J Cancer Res; 2022; 12(6):2558-2575. PubMed ID: 35812057
[TBL] [Abstract][Full Text] [Related]
13.
Liu Q; Zhai J; Kong X; Wang X; Wang Z; Fang Y; Wang J
Mol Ther Oncolytics; 2020 Jun; 17():153-168. PubMed ID: 32346606
[TBL] [Abstract][Full Text] [Related]
14. Targeting tryptophan availability to tumors: the answer to immune escape?
Badawy AA
Immunol Cell Biol; 2018 Nov; 96(10):1026-1034. PubMed ID: 29888434
[TBL] [Abstract][Full Text] [Related]
15. The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis.
Too LK; McQuillan JA; Ball HJ; Kanai M; Nakamura T; Funakoshi H; McGregor IS; Hunt NH
Behav Brain Res; 2014 Aug; 270():179-95. PubMed ID: 24844751
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of oxindoles as promising inhibitors of the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1.
Paul S; Roy A; Deka SJ; Panda S; Srivastava GN; Trivedi V; Manna D
Medchemcomm; 2017 Aug; 8(8):1640-1654. PubMed ID: 30108875
[TBL] [Abstract][Full Text] [Related]
17. Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications.
Ye Z; Yue L; Shi J; Shao M; Wu T
J Cancer; 2019; 10(12):2771-2782. PubMed ID: 31258785
[TBL] [Abstract][Full Text] [Related]
18. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the
Brooks AK; Lawson MA; Rytych JL; Yu KC; Janda TM; Steelman AJ; McCusker RH
Front Immunol; 2016; 7():422. PubMed ID: 27799931
[TBL] [Abstract][Full Text] [Related]
20.
Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
